Health Care Archives - Page 13 of 478

2 minute read

Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply

May 29, 5:37 AM

The global market for weight-loss drugs is expected to reach a staggering $150 billion by the early 2030s, a significant increase from the previous forecast of $100 billion. This surge is attributed to the growing availability of weight-loss medications.

HRTS

2 minute read

Merck Reportedly Nearing $1.3B Acquisition Of EyeBio To Expand Eye-Care Market Presence

By Benzinga Neuro

May 29, 4:36 AM

Merck & Co is reportedly on the verge of acquiring EyeBio, an eye-drug company, for a sum of $1.3 billion. This acquisition is expected to significantly expand Merck's presence in the rapidly growing eye-care market.

MRK

2 minute read

Arcturus Therapeutics’ Early Cystic Fibrosis Trial Results Encouraging – Analyst Cautiously Optimistic

By Vandana Singh

May 28, 2:55 PM

Arcturus Therapeutics' early Phase 1 results show ARCT-032 is safe and well-tolerated, with promising improvements in lung function.

ARCT

2 minute read

With FDA Decision Date Approaching, Analyst Downgrades Sarepta On Balanced Risk And Reward

By Vandana Singh

May 28, 2:40 PM

RBC Capital Markets downgrades Sarepta Therapeutics following increased FDA label expansion expectations for Elevidys and recent stock surge.

PFE

2 minute read

Why Is AstraZeneca Stock Trading Lower On Tuesday?

By Vandana Singh

May 28, 2:32 PM

AstraZeneca's TROPION-Lung01 phase 3 trial for datopotamab deruxtecan in NSCLC showed OS improvement in nonsquamous patients. While the overall trial did not reach statistical significance.

AZN

1 minute read

Why Is Agios Pharmaceuticals Stock Trading Higher On Tuesday?

By Vandana Singh

May 28, 1:00 PM

Agios Pharmaceuticals sells its 15% royalty rights on U.S. net sales of Servier's vorasidenib to Royalty Pharma for $905 million upon FDA approval.

AGIO

1 minute read

Semler Scientific +28% After Adopting Bitcoin As Primary Treasury Reserve Asset: What’s Going On?

By Nabaparna Bhattacharya

May 28, 12:05 PM

Semler Scientific's shares surge after adopting Bitcoin as its primary treasury reserve asset, purchasing 581 bitcoins for $40 million.

BTC

1 minute read

Asahi Kasei Makes $1.1B Offer For Swedish Drugmaker Calliditas Therapeutics, Enhancing Pharma Growth Strategy

By Vandana Singh

May 28, 12:03 PM

Asahi Kasei's $1.1 billion acquisition of Calliditas Therapeutics offers 208 SEK per share in cash. The deal boosts Asahi Kasei's global presence in immunology and renal disease markets, aligning with its strategic growth and expansion in the U.S. and Europe.

CALT

2 minute read

Novo Nordisk Faces Scrutiny Over High Prices of Ozempic And Wegovy, Blames US Health System

By Vandana Singh

May 28, 11:59 AM

Novo Nordisk retains around 60% of the list price for its diabetes and obesity medications, Ozempic and Wegovy, after rebates and fees.

NVO

1 minute read

Why Mid-Cap Corcept Therapeutics Stock Trading Higher On Tuesday?

By Vandana Singh

May 28, 9:39 AM

Corcept Therapeutics announced the GRACE Phase 3 trial results for relacorilant in Cushing's syndrome, showing significant improvements in hypertension and hyperglycemia.

CORT